0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Deficiency of the Intramembrane Protease SPPL2a Alters Antimycobacterial Cytokine Responses of Dendritic Cells.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Signal peptide peptidase-like 2a (SPPL2a) is an aspartyl intramembrane protease essential for degradation of the invariant chain CD74. In humans, absence of SPPL2a leads to Mendelian susceptibility to mycobacterial disease, which is attributed to a loss of the dendritic cell (DC) subset conventional DC2. In this study, we confirm depletion of conventional DC2 in lymphatic tissues of SPPL2a-/- mice and demonstrate dependence on CD74 using SPPL2a-/- CD74-/- mice. Upon contact with mycobacteria, SPPL2a-/- bone marrow-derived DCs show enhanced secretion of IL-1β, whereas production of IL-10 and IFN-β is reduced. These effects correlated with modulated responses upon selective stimulation of the pattern recognition receptors TLR4 and Dectin-1. In SPPL2a-/- bone marrow-derived DCs, Dectin-1 is redistributed to endosomal compartments. Thus, SPPL2a deficiency alters pattern recognition receptor pathways in a CD74-dependent way, shifting the balance from anti- to proinflammatory cytokines in antimycobacterial responses. We propose that in addition to the DC reduction, this altered DC functionality contributes to Mendelian susceptibility to mycobacterial disease upon SPPL2a deficiency.

          Related collections

          Author and article information

          Journal
          J Immunol
          Journal of immunology (Baltimore, Md. : 1950)
          The American Association of Immunologists
          1550-6606
          0022-1767
          January 01 2021
          : 206
          : 1
          Affiliations
          [1 ] Institute of Physiological Chemistry, Technische Universität Dresden, D-01307 Dresden, Germany.
          [2 ] Laboratory of Dendritic Cell Biology, Department of Dermatology, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital Erlangen, D-91052 Erlangen, Germany.
          [3 ] Medical Immunology Campus Erlangen, D-91054 Erlangen, Germany.
          [4 ] Deutsches Zentrum Immuntherapie, D-91054 Erlangen, Germany.
          [5 ] Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg, D-91054 Erlangen, Germany.
          [6 ] Biochemical Institute, Christian-Albrechts-University Kiel, D-24118 Kiel, Germany.
          [7 ] Priority Program Infections, Division of Cellular Microbiology, Research Center Borstel, Leibniz Lung Center, and German Center for Infection Research, partner site Borstel, D-23845 Borstel, Germany; and.
          [8 ] Institute of Medical Microbiology and Hygiene, Technische Universität Dresden, D-01307 Dresden, Germany.
          [9 ] Institute of Physiological Chemistry, Technische Universität Dresden, D-01307 Dresden, Germany; bernd.schroeder@tu-dresden.de.
          Article
          jimmunol.2000151
          10.4049/jimmunol.2000151
          33239420
          e4052ef9-f323-44a5-b679-d30d7e9346eb
          History

          Comments

          Comment on this article